Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06053398 · ClinicalTrials.gov registry record · Early Phase 1

Vasopressor Outcomes in Spine Surgery

A Early Phase 1 study, sponsored by University of Texas Southwestern Medical Center.

Completed
Registry status
Early Phase 1
Development phase
101
Enrollment target

NCT06053398: Completed Early Phase 1 study, sponsored by University of Texas Southwestern Medical Center.

NCT06053398 is a Early Phase 1 study that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 101 participants, above the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (91% higher). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06053398, a Early Phase 1 study, has completed, sponsored by University of Texas Southwestern Medical Center.

COMPLETED
Registry status
Early Phase 1
Development phase
101 participants
Enrollment target

Study Summary

This is a prospective, randomized control trial comparing norepinephrine versus phenylephrine for vasopressor support in patients undergoing elective spinal fusion surgery.

Primary Outcome

Total intraoperative vasopressor requirement

Interventions

  • DRUG Norepinephrine
  • DRUG Phenylephrine

Trial Details

FieldValue
Enrollment Target 101 participants
Start Date 2023-11-21
Est. Completion 2024-12-30
Phase Early Phase 1

What the finished NCT06053398 record still lists

NCT06053398 is an interventional study that assigns participants to a tested intervention. The registered 101 participants enrollment target is mid-sized for trials with a published cap, above the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (91% higher).

The record links to 0 conditions, and to 2 interventions - of which Norepinephrine is the first listed.

NCT06053398 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT06053398 about?

NCT06053398 is a clinical study titled "Vasopressor Outcomes in Spine Surgery". This is a prospective, randomized control trial comparing norepinephrine versus phenylephrine for vasopressor support in patients undergoing elective spinal fusion surgery.

What is the current status of trial NCT06053398?

This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 101 participants. The study started on 2023-11-21. Estimated completion is 2024-12-30.

What interventions are being tested in trial NCT06053398?

The interventions under investigation include: Norepinephrine (DRUG), Phenylephrine (DRUG).

Who is sponsoring clinical trial NCT06053398?

This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT06053398's enrollment target sits among peer trials

101 182nd of 2000 higher than 1,818 of 2,000 other Early Phase 1 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04033497 · 101 participants · NA

    Treatment Response Assessment Maps to Delineate Necrosis From Tumor After Stereotactic Radiation in Brain Metastases

  • NCT05111574 · 101 participants · Phase 2

    Using Nivolumab Alone or With Cabozantinib to Prevent Mucosal Melanoma Return After Surgery

  • NCT05984680 · 101 participants

    COPD Care Pathway Among Patients With Cancer

  • NCT06266299 · 101 participants · Phase 1

    A Study of KK2269 in Adult Participants With Solid Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06053398, the US trial registry maintained by the National Library of Medicine. NCT06053398 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.